Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tyvek Is Tyvek, FDA Affirms In Letter To DuPont

This article was originally published in The Gray Sheet

Executive Summary

The industrial giant DuPont has gained validation from FDA that the vast array of medical device companies employing its Tyvek material for sterile barrier systems will not need to submit new 510(k)s or supplements when they transition to versions manufactured with new flash-spinning technology. Newly manufactured Tyvek remains "functionally equivalent" to legacy versions, the agency said.

Advertisement
Advertisement
UsernamePublicRestriction

Register

MT034262

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel